Benitec Biopharma Inc.
BNTCDrugs in Pipeline
1
Phase 3 Programs
0
Upcoming Catalysts
1
Next Catalyst
Sep 28, 2026
6wMarket Overview
Stock performance and key metrics
1 upcoming, 0 past
How BNTC's past catalysts played out
| Drug Name | Phase | Indication | Designations | Patent |
|---|---|---|---|---|
BB-401 | Phase 2 | Head and Neck Squamous Cell Carcinoma | - | - |
Full breakdown — the signals behind the verdict
Frequently asked questions
What is in Benitec Biopharma Inc.'s drug pipeline?→
CatalystAlert tracks 1 drug candidate in Benitec Biopharma Inc.'s (BNTC) pipeline across Phase 2. Its lead program is BB-401 (Phase 2). Each drug's phase, indication and upcoming catalysts are listed on this page.
When is Benitec Biopharma Inc.'s next FDA catalyst?→
Benitec Biopharma Inc.'s (BNTC) next tracked catalyst is a Earnings expected September 28, 2026. See the catalyst timeline on this page for the full schedule of PDUFA dates, trial readouts and FDA events.
How do I track BNTC biotech catalysts?→
Add BNTC to your CatalystAlert watchlist for alerts ahead of each catalyst, and follow Benitec Biopharma Inc.'s live catalyst calendar, drug pipeline and clinical-trial timeline on this page — sourced from ClinicalTrials.gov, FDA and SEC filings.